A method of performing dialysis includes: recirculating a dialysis fluid from a patient or a dialyzer for at least two cycles, each cycle contacting the dialysis fluid first with a zirconium phosphate layer followed by at least one of a urease layer, a zirconium oxide layer, or a carbon layer; storing the recirculated dialysis fluid in a storage container; and transferring the dialysis fluid from the storage container to the patient or the dialyzer. In one example, the zirconium phosphate layer and the at least one of the urease layer, the zirconium oxide layer, or the carbon layer is provided by a sorbent cartridge.
A61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
B01J 20/02 - Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
B01J 20/06 - Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising oxides or hydroxides of metals not provided for in group
B01J 20/20 - Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising carbon obtained by carbonising processes
B01J 20/24 - Naturally occurring macromolecular compounds, e.g. humic acids or their derivatives
B01J 20/28 - Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
A renal therapy system is disclosed. In an example, the renal therapy system includes a home renal therapy machine that stores, to a log file, dates of when renal therapies were performed and a type of each renal therapy that was performed. The system also includes a server that receives the log file from the home renal therapy machine. The server compares the dates and types of performed renal therapies stored in the log file to a device program that specifies dates for performing renal therapies and the types of renal therapies to be performed. The server displays a flag in a user interface of a clinician computer when there is a deviation from the comparison.
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
G16H 20/10 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 20/40 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
G16H 40/40 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
3.
DIALYSIS SYSTEM HAVING EXTERNAL TUBING SURFACE CLEANING
A peritoneal dialysis (“PD”) system includes a housing, a PD fluid pump housed by the housing, and a reusable line in fluid communication with the PD fluid pump. The reusable line is configured to be pulled into the housing. The PD system also includes an external tubing surface cleaning unit positioned and arranged to at least one of (i) remove debris from at least a portion of the exterior of the reusable line as it is pulled into the housing, or (ii) apply disinfectant to at least the portion of the exterior of the reusable line as it is pulled into the housing.
A peritoneal dialysis (“PD”) system includes a housing, a PD fluid pump housed by the housing, an inline heater in fluid communication with the PD fluid pump, a temperature sensor, and a control unit. The PD fluid pump and the inline heater are under control of the control unit, which receives a temperature signal from the temperature sensor. The control unit, in one embodiment, is configured to perform a heat disinfection sequence in which the control unit causes the PD fluid pump to pump disinfection fluid in a forward direction, while the inline heater heats the disinfection fluid, and in a reverse direction after the temperature signal indicates that a temperature of the disinfection fluid has fallen to or has fallen below a minimum disinfection temperature.
The invention provides a neck-worn sensor (referred to herein as the ‘necklace’) that is a single, body-worn system that measures the following parameters from an ambulatory patient: heart rate, pulse rate, pulse oximetry, respiratory rate, temperature, thoracic fluid levels, stroke volume, cardiac output, and a parameter sensitive to blood pressure called pulse transit time. From stroke volume, a first algorithm employing a linear model can estimate the patient's pulse pressure. And from pulse pressure and pulse transit time, a second algorithm, also employing a linear algorithm, can estimate systolic blood pressure and diastolic blood pressure. Thus, the necklace can measure all five vital signs along with hemodynamic parameters. It also includes a motion-detecting accelerometer, from which it can determine motion-related parameters such as posture, degree of motion, activity level, respiratory-induced heaving of the chest, and falls.
A61B 5/0205 - Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
A61B 5/02 - Measuring pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography; Heart catheters for measuring blood pressure
A61B 5/1455 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value using optical sensors, e.g. spectral photometrical oximeters
A medical device data back-association system, apparatuses, and methods are disclosed. In an example embodiment, an electronic medical record memory receives, while an infusion pump is administering a medication to a patient, an identifier message including at least two of a device identifier of the infusion pump, a patient identifier of the patient, and a medication order identifier of a medication being administer by the infusion pump. The memory creates an association between an electronic medical record (“EMR”) of the patient and the infusion pump using the identifier message. The memory next receives, after the association between the EMR of the patient and the infusion pump, infusion pump data from the infusion pump. The infusion pump data includes the device identifier. The memory then stores the infusion pump data to the EMR of the patient based on the created association between the EMR of the patient and the infusion pump.
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 40/60 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
7.
SYSTEMS AND METHODS FOR CONTROLLING PARTIAL DELIVERY PUMPING IN INFUSION SYSTEMS
A method and system for delivering partial boluses using infusion pumps is disclosed. An example method includes storing a programmed dose volume to be administered in response to a request from a patient and instructing the pump to begin dispensing the programmed dose volume of fluid from the fluid supply. The method further includes receiving an indication that the pump has stopped pumping, determining a partial dose volume, and when the partial dose volume equals a value greater than zero, generate an alarm that the fluid supply is depleted. Additionally, the method includes exchanging the depleted fluid supply with a subsequent fluid supply, dispensing from the subsequent fluid supply the partial dose volume, and preventing any subsequent dispensing of fluid from the subsequent fluid supply for a programed lockout period.
A connection assist device, which secures a connection of a catheter connector end to a patient line connector end, is provided. In one embodiment, the assist device includes a patient line shield, a catheter shield, and a minicap catcher. Each shield and catcher includes a first half and a second half. The patient line shied houses the patient line connector end. The catheter shield houses the catheter connector end. The minicap catcher is sized to receive a minicap initially protecting the catheter connector end. During use, the minicap catcher is inserted into the catheter shield and rotated to remove the minicap, after which the minicap connector is removed. The patient line shield is then inserted into the catheter shield housing to connect the catheter connector end to the patient line connector end.
A peritoneal dialysis system comprises a cycler including a dialysis fluid pump, a plurality of valve actuators, and a control unit configured to control the dialysis fluid pump and the plurality of valve actuators; and a drain line including a disposable portion, a reusable portion, and a drip chamber located between the disposable portion and the reusable portion, the drip chamber configured to create an air column that dissuades pathogen migration from the reusable portion to the disposable portion. The dialysis fluid pump may include a pneumatic valve manifold and an air pump positioned and arranged to supply pneumatic pressure to the pneumatic valve manifold. The disposable portion of the drain line may be provided as part of a disposable set including a pump actuation portion operable with the dialysis fluid pump, and a valve actuation portion operable with the plurality of valve actuators.
A peritoneal dialysis system includes a cycler having a pneumatic valve manifold, an air pump positioned and arranged to supply pneumatic pressure to the pneumatic valve manifold without intervening pneumatic storage, a pneumatic pressure sensor positioned and arranged to detect pneumatic pressure, and a control unit configured to use an output of the pressure sensor as feedback to adjust the air pump according to a set pneumatic pressure; and a disposable set including a pod pump having a flexible sheet, one side of the flexible sheet positioned and arranged during operation to receive pneumatic pressure via the air pump and pneumatic valve manifold.
A cartridge assembly for a filling machine includes a plurality of containers. Each container includes a volume and a stem connected to the volume. A connection line grid is in fluid communication with each stem of the plurality of containers. The connection line grid includes a first row connected to one or more containers of the plurality of containers and a second row connected to one or more containers of the plurality of containers. A filter assembly is coupled to the connection line grid.
B65B 65/00 - MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING - Details peculiar to packaging machines and not otherwise provided for; Arrangements of such details
B65B 3/00 - Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans or jars
B65B 3/04 - Methods of, or means for, filling the material into the containers or receptacles
B65B 3/12 - Methods of, or means for, filling the material into the containers or receptacles by application of pressure to material mechanically, e.g. by pistons or pumps
B65B 39/00 - Nozzles, funnels or guides for introducing articles or materials into containers or wrappers
B65B 51/14 - Applying or generating heat or pressure or combinations thereof by reciprocating or oscillating members
B65B 51/22 - Applying or generating heat or pressure or combinations thereof by friction or ultrasonic or high-frequency electrical means
B65B 55/12 - Sterilising contents prior to, or during, packaging
B65B 61/06 - Auxiliary devices, not otherwise provided for, for operating on sheets, blanks, webs, binding material, containers or packages for severing webs, or for separating joined packages by cutting
B65B 57/04 - Automatic control, checking, warning or safety devices responsive to absence, presence, abnormal feed, or misplacement of binding or wrapping material, containers, or packages and operating to control, or to stop, the feed of such material, containers, or packages
12.
PERITONEAL DIALYSIS SYSTEM INCLUDING PERISTALTIC PUMP
A peritoneal dialysis (“PD”) system includes a cycler having a peristaltic pump actuator; a disposable set including a pressure sensing manifold including first and second pressure sensing pods, a drain line and a first dialysis fluid/heater container line in fluid communication with the first pressure sensing pod, and at least one dialysis fluid container line and a patient line in fluid communication with the second pressure sensing pod; and a control unit programmed to operate the peristaltic pump actuator (i) in a first direction to pump fresh dialysis fluid along the at least one additional dialysis fluid container line into the first dialysis fluid/heater line and (ii) in a second direction to pump heated fresh dialysis fluid along the first dialysis fluid/heater line into the patient line. The pump actuator may be operated in the first direction again to pump used dialysis fluid from the patient to a drain.
A manifold assembly for a peritoneal dialysis apparatus, comprises: a casing delimiting internally a first compartment and a second compartment; a yielding pump tube having a first end connected or connectable to the first compartment and a second end connected or connectable to the second compartment. The yielding pump tubes extends outside the casing to be coupled to a peristaltic pump of a cycler of a peritoneal dialysis apparatus. The second compartment delimits expansion chambers configured to attenuate pressure pulsations from the peristaltic pump.
A method for calibrating a peristaltic pump in a medical apparatus comprises: rotating the peristaltic pump of a predetermined rotation to pump a liquid from a fluid source from a first compartment into a second compartment of a manifold assembly, raising a level of the liquid in the second compartment and compressing air in an air buffer volume of the manifold assembly; measuring a pressure of air in the air buffer volume; calculating, from the measured pressure, a variation of liquid volume in the second compartment due to the rotation of the peristaltic pump; calculating, from the variation of liquid volume and the predetermined rotation, a stroke liquid volume of the peristaltic pump.
A method for producing sterile solution-filled containers includes positioning a cartridge onto a filling machine. The cartridge includes a plurality of containers, a filter assembly, and a connection line in fluid communication with the filter assembly. Each of the plurality of containers includes a volume and a stem in fluid communication with the volume and in fluid communication with the connection line. The method includes coupling the cartridge to a feed line in fluid communication with a mix tank, activating a pump coupled to the feed line, and at least partially filling one or more of the volumes associated with the plurality of containers by pumping fluid through the feed line, the filter assembly, and the connection line to create one or more at least partially filled containers. Further, the method includes sealing and separating each of the filled and sealed containers from the connection line.
B65B 57/04 - Automatic control, checking, warning or safety devices responsive to absence, presence, abnormal feed, or misplacement of binding or wrapping material, containers, or packages and operating to control, or to stop, the feed of such material, containers, or packages
B65B 3/00 - Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans or jars
B65B 3/04 - Methods of, or means for, filling the material into the containers or receptacles
B65B 3/12 - Methods of, or means for, filling the material into the containers or receptacles by application of pressure to material mechanically, e.g. by pistons or pumps
B65B 37/06 - Supplying or feeding fluent-solid, plastic, or liquid material, or loose masses of small articles, to be packaged by pistons or pumps
B65B 39/00 - Nozzles, funnels or guides for introducing articles or materials into containers or wrappers
B65B 51/22 - Applying or generating heat or pressure or combinations thereof by friction or ultrasonic or high-frequency electrical means
B65B 51/14 - Applying or generating heat or pressure or combinations thereof by reciprocating or oscillating members
B65B 55/12 - Sterilising contents prior to, or during, packaging
B65B 61/06 - Auxiliary devices, not otherwise provided for, for operating on sheets, blanks, webs, binding material, containers or packages for severing webs, or for separating joined packages by cutting
B65B 65/00 - MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING - Details peculiar to packaging machines and not otherwise provided for; Arrangements of such details
16.
MANIFOLD ASSEMBLY FOR A PERITONEAL DIALYSIS APPARATUS AND PERITONEAL DIALYSIS APPARATUS COMPRISING SAID MANIFOLD ASSEMBLY
A manifold assembly for a peritoneal dialysis apparatus, comprises: a casing delimiting internally a first compartment and a second compartment; a yielding pump tube having a first end connected or connectable to the first compartment and a second end connected or connectable to the second compartment. The yielding pump tube extends outside the casing to be coupled to a peristaltic pump of a cycler of a peritoneal dialysis apparatus. A first pump port and a second pump port are placed on a first side of the casing and ports are placed on a second side of the casing, opposite the first side.
A medical apparatus comprises a medical machine and a manifold assembly mounted or mountable on the medical machine. The medical machine comprises an occlusion element comprising a plunger configured to be moved between a retracted position, in which the plunger is spaced from a soft membrane of the manifold and a port of the manifold is open, and a forward position, in which the plunger accommodated in a seat of the port and the soft membrane is trapped between the plunger and the seat to close the port. The occlusion element comprises a membrane tensioner of mechanical type. The membrane tensioner is configured to raise the soft membrane away from the seat when the plunger goes back to the retracted position and to counteract a possible negative pressure tending to keep the port closed.
A peritoneal dialysis (“PD”) system includes a housing; a PD fluid pump housed by the housing; a filter set including a filter housing and a hydrophilic filter membrane dividing an upstream chamber from a downstream chamber; a dual lumen patient line including a fresh PD fluid lumen in fluid communication with the upstream chamber and a used PD fluid lumen in fluid communication with the downstream chamber; a pressure sensor positioned and arranged to provide a pressure sensor output indicative of pressure in the downstream chamber of the filter housing; and a control unit configured to perform a pressure integrity test on the hydrophilic filter membrane by monitoring the pressure sensor output over a period of time, the pressure sensor output indicative of a negative pressure created in the downstream chamber by the PD fluid pump. A pressure drop test for evaluating the filter membrane is also disclosed.
A method of performing peritoneal dialysis (PD), the method comprising: delivering a PD fluid to the peritoneal cavity of a patient through a PD catheter; dwelling the PD fluid within the peritoneal cavity; and while dwelling the PD fluid, removing a biofilm from the PD catheter wall using a biofilm removing solution. The biofilm removing solution comprises: sodium citrate dihydrate; citric acid anhydrous; sodium lauryl sulfate; and water. In another aspect, a method for decontaminating a peritoneal dialysis (PD) catheter and removing a biofilm from the PD catheter and a transfer set, the method comprising: providing a biofilm removing solution; transferring the biofilm removing solution into a syringe; connecting the syringe to a transfer set of the PD catheter; and filling the transfer set and the PD catheter with the biofilm removing solution.
A method of performing peritoneal dialysis (PD), the method comprising: delivering a PD fluid to the peritoneal cavity of a patient through a PD catheter; dwelling the PD fluid within the peritoneal cavity; and while dwelling the PD fluid, removing a biofilm from the PD catheter wall using a biofilm removing solution. The biofilm removing solution comprises: sodium citrate dihydrate; citric acid anhydrous; sodium lauryl sulfate; and water. In another aspect, a method for decontaminating a peritoneal dialysis (PD) catheter and removing a biofilm from the PD catheter and a transfer set, the method comprising: providing a biofilm removing solution; transferring the biofilm removing solution into a syringe; connecting the syringe to a transfer set of the PD catheter; and filling the transfer set and the PD catheter with the biofilm removing solution.
Disclosed herein is a water purification apparatus capable of being cleaned at a point of care, and methods for cleaning the water purification apparatus at the point of care. The water purification apparatus and the methods provide an efficient use of a heater for heat disinfection the water purification apparatus, e.g. by recirculating heated fluid to further heat the fluid. Several different cleaning programs are provided that may be utilized for cleaning different parts of the water purification apparatus.
B01D 61/48 - Apparatus therefor having one or more compartments filled with ion-exchange material
C02F 1/00 - Treatment of water, waste water, or sewage
C02F 1/44 - Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
C02F 1/469 - Treatment of water, waste water, or sewage by electrochemical methods by electrochemical separation, e.g. by electro-osmosis, electrodialysis, electrophoresis
A dialysis system and dialysis machine or cycler are provided that decrease a disposable set's cost and complexity. The dialysis machine or cycler includes a weigh scale on which multiple fluid supply containers containing dialysis fluid, and a drain trolley, are positioned. The fluid supply containers may be elevated relative to the drain trolley. The drain trolley is sized to contain all of the effluent drained from a patient during a dialysis treatment. The fluid supply containers are in fluid communication with one another and arranged one of top of the other. A control unit may control fill, dwell and drain cycles by controlling the operation of a pump and a valve. Dialysis fluid from the bottom-most fluid supply container may be pumped into a patient. The valve may be opened to allow effluent to drain from the patient to the drain trolley by way of gravity.
A medical fluid container assembling system and method are disclosed. The system includes a coiled catheter pallet for receiving a catheter tip portion of a coiled catheter. The system also includes a coiled catheter preparation unit configured to place the coiled catheter on the coiled catheter pallet in a predetermined posture, and cause the catheter tip portion of the coiled catheter to extend a predetermined length. The system further includes a container body pallet for receiving a container tube of a container body. Additionally, the system includes a container body preparation unit configured to place the container body on the container body pallet in a predetermined posture, and cause the container tube of the container body to extend a predetermined length. The system also includes a container tube expander, a catheter tip gluing device, and an assembling mechanism configured to insert the catheter tip portion into the container tube.
A peritoneal dialysis (“PD”) system includes a PD machine including a housing, a PD fluid pump housed by the housing, a plurality of PD fluid lines, and a plurality of PD fluid line connectors positioned and arranged at the housing to accept distal ends of the PD fluid lines to perform a disinfection sequence. The PD system also includes a disinfection unit including a disinfection unit housing, a PD fluid line connector positioned and arranged at the disinfection unit housing for receiving one of the PD fluid lines of the PD machine for the disinfection sequence, a line extending from the disinfection unit housing for connecting to one of the PD fluid line connectors of the PD machine for the disinfection sequence, and a disinfection fluid pump housed by the disinfection unit for pumping disinfection fluid during the disinfection sequence.
A peritoneal dialysis (“PD”) system includes a PD fluid pump, a dual lumen patient line including fresh and used PD fluid lumens, a filter set in fluid communication with the fresh and used PD fluid lumens, a valve provided either with a patient's transfer set or with the filter set, and a control unit configured, after a patient drain, to (i) prompt a patient or caregiver to close the valve when the valve is a manual valve, or (ii) cause the valve to close automatically when the valve is an electrically or pneumatically controlled valve. The control unit is further configured to cause the PD fluid pump, with the valve closed, to pump fresh, heated PD fluid into the fresh PD fluid lumen to displace unheated PD fluid from the fresh PD fluid lumen, through the filter set, into the used PD fluid lumen. A corresponding method is also disclosed.
A peritoneal dialysis (“PD”) system includes a housing, a PD fluid pump housed by the housing, and a reusable patient line extending from the housing. The reusable patient line includes a distal end configured to be connected to a patient line connector provided by the housing. The PD system also includes at least one reusable PD fluid line extending from the housing, the at least one reusable PD fluid line including a distal end configured to be connected to a PD fluid line connector provided by the housing. The PD system further includes a control unit configured to cause the PD fluid pump to apply a negative pressure to at least one of the reusable patient line or the at least one reusable PD fluid line when connected, respectively, to the patient line connector or the PD fluid line connector.
A system is disclosed for the automated collection of dialysis and physiological data. An example system includes a dialysis machine configured to generate dialysis data and a wireless peripheral device configured to generate physiological data. The system also includes a personal digital device including an application configured to communicatively couple to the dialysis machine. The application is further configured to detect being within a wireless range of the wireless peripheral device, pair with the wireless peripheral device, receive the physiological data from the wireless peripheral device, and transmit the received physiological data to the dialysis machine. The dialysis machine is configured to store the received physiological data in conjunction with the dialysis data.
G16H 20/40 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
28.
PERITONEAL DIALYSIS SYSTEM HAVING DISINFECTION GAS RELIEF
A peritoneal dialysis (“PD”) system includes a PD fluid pump, a disinfection loop including the PD fluid pump, the disinfection loop including PD fluid used for disinfecting the disinfection loop, and an acid solution source positioned and arranged to supply an acid solution to the disinfection loop during disinfection using the PD fluid. The disinfection loop includes an airtrap and a pressure sensor positioned and arranged to sense PD fluid pressure during disinfection, the pressure sensor outputting to a control unit, the control unit configured to open at least one gas valve located along at least one gas line leading to an upper portion of the airtrap when the PD fluid pressure reaches or exceeds a threshold PD fluid pressure due to gas formation caused by mixing the acid solution with the PD fluid.
A peritoneal dialysis fluid generation system including water purification equipment configured to provide purified water; a presterilized tubing set including a container for storing peritoneal dialysis fluid; at least one glucose or buffer concentrate; and a hemodialysis machine in fluid communication with the water purification equipment. The hemodialysis machine includes at least one mixing pump for mixing the at least one glucose or buffer concentrate with the purified water to form peritoneal dialysis fluid, a dialysis fluid pump for delivering the peritoneal dialysis fluid to the container, and a control unit configured to control the at least one mixing pump to form the peritoneal dialysis fluid and the dialysis fluid pump to deliver the peritoneal dialysis fluid to the container.
A peritoneal dialysis fluid circuit comprising a patient line, a delivery line configured to supply fresh dialysis fluid towards the patient line, a withdrawal line configured to withdraw spent dialysis fluid from the patient line, a first pump arranged on the delivery line and configured to supply fresh dialysis fluid towards the patient line, and a second pump arranged on the withdrawal line and configured to withdraw spent dialysis fluid from the patient line. The fluid circuit further comprises a control unit configured to perform a peritoneal dialysis procedure. The peritoneal dialysis procedure comprises commanding activation of the first pump at a first flow rate, and activation of the second pump at a second flow rate different from the first flow rate: the first pump and the second pump are active simultaneously to provide the first flow rate and the second flow rate.
Methods, systems, and apparatuses for integrating medical device data are disclosed. In an example embodiment, a server receives infusion therapy progress data that is generated by an infusion pump and renal failure therapy progress data that is generated by a renal failure therapy machine. The server also receives physiological data that is generated by at least one physiological sensor. The server determines fluid balance data based on a difference between the infusion therapy progress data and the renal failure therapy progress data. The server stores the fluid balance data in conjunction with hemodynamic information from the physiological data to a patient's medical record.
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
H04L 67/12 - Protocols specially adapted for proprietary or special-purpose networking environments, e.g. medical networks, sensor networks, networks in vehicles or remote metering networks
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
G16H 20/40 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
A personalized chronic care apparatus is disclosed herein. An example apparatus includes a server operating over a network, software stored on the server, and a compliance entry feature configured to receive compliance information related to a patient. The software includes an automated learning method for creating an overall kidney maintenance plan that specifies one or more controllable variables as actions performed by the patient to prevent or reduce complications associated with chronic kidney disease (“CKD”). The automated learning method is configured to perform an evaluation to determine whether a selected controllable variable is to be included in the overall kidney maintenance plan by confirming when (i) a worsening of kidney function is not determined between first evaluation data and second evaluation data over a testing period, and (ii) the compliance information provides a confirmation that the selected controllable variable was modified over the testing period.
G16H 20/30 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
G16H 20/70 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
G16H 20/10 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
G16H 20/60 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
A hemodynamic management system, apparatus, and method are disclosed herein. An example hemodynamic management apparatus includes a display interface screen and a processor configured to access a patient medical record using a patient identifier and determine, from the patient medical record, a new infusion start event associated with an infusion pump that is fluidly connected to a patient. The processor also causes the display interface screen to display an infusion line mapping interface that shows a graphical illustration of a human body and potential access sites, prompt for selection of an access site within the infusion line mapping interface, and after receiving a selection of an access site, associate an infusion pump identifier and the selected access site. The processor also causes the display interface screen to display information from the new infusion start event in conjunction with the selected access site shown within the infusion line mapping interface.
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
G16H 70/40 - ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
34.
MEDICAL FLUID SYSTEM HAVING SYSTEMS AND METHODS FOR VERIFYING VOLTAGE AND ANALOG-TO-DIGITAL CONVERTER MEASUREMENTS
Systems and methods are disclosed for verifying reference voltage and analog-to-digital converter (“ADC”) values during medical fluid treatment. An example system comprises a control circuit including control ADC devices associated with respective control sensors to facilitate medical fluid treatment; and a protective circuit including protective ADC devices associated with protective sensors, wherein the control circuit and the protective circuit are galvanically isolated from one another; and a computing device having a memory and a processor. The computing device may be configured to initiate a pretreatment that exposes the control sensors and the protective sensors to common pretreatment conditions (e.g., temperature and pressure); receive, during the pretreatment, control ADC values and protective ADC values; and register an error for one or both of the control circuit or the protective circuit based on a comparison of a control ADC value with a protective ADC value.
An infusion pump for delivering an intravenous (“IV”) fluid includes a housing having a vertical orientation when the infusion pump is positioned for operation. The housing has a top side configured to engage a portion of an IV tube. The top side includes a tube window configured to enable the portion of the IV tube to pass through the top side of the housing. The infusion pump also includes a door hingedly connected to the housing. The door is configured to rotate between an open position and a closed position. The door includes a roof configured to contact the top side of the housing. The door includes a lip configured to enable the portion of the IV tube to pass through the door.
A medical fluid generation system is disclosed. In an example, a peritoneal dialysis fluid generation system includes water purification equipment configured to provide purified water; a presterilized tubing set including a container for storing peritoneal dialysis fluid; at least one glucose or buffer concentrate; and a hemodialysis machine in fluid communication with the water purification equipment. The hemodialysis machine includes at least one mixing pump for mixing the at least one glucose or buffer concentrate with the purified water to form peritoneal dialysis fluid, a dialysis fluid pump for delivering the peritoneal dialysis fluid to the container, and a control unit configured to control the at least one mixing pump to form the peritoneal dialysis fluid and the dialysis fluid pump to deliver the peritoneal dialysis fluid to the container.
A dialysis system includes a dialysis machine comprising a motorized autoconnection mechanism, a fluid supply line connected to a source of dialysis fluid, and a cassette for use with the dialysis machine. The cassette includes a frame, a pump chamber within the frame, a first set of valves for routing the dialysis fluid from the fluid supply line to the pump chamber, and a second set of valves for routing the dialysis fluid from the pump chamber to a patient line. The cassette also includes a plurality of ports communicating with the first and second set of valves. Each port includes an integral spike. The motorized autoconnection mechanism is configured to move the fluid supply line and the patient line automatically so as to be spiked open respectively by the plurality of ports of the cassette.
A peritoneal dialysis (“PD”) system includes a cycler including an actuation surface having a peristaltic pump actuator; a manifold assembly including a rigid manifold having first and second chambers (110a, 110b), the rigid manifold configured and arranged to be abutted against the actuation surface for operation, a peristaltic pump tube (124gh) extending from the first chamber (110a) to the second chamber (110b) of the rigid manifold, a dialysis fluid container line (124b) extending from the first chamber (110a), and a branch line (124c) extending between the dialysis fluid container line (124b) and the second chamber (110b); and a control unit configured to cause the peristaltic pump actuator to actuate the peristaltic pump tube (124gh) to pump dialysis fluid from the branch line (124c) into the second chamber (110b) and from the second chamber (110b) into the first chamber (110a).
A peritoneal dialysis (“PD”) system includes a cycler including an actuation surface having a peristaltic pump actuator; at least one pair of capacitive sensing plates; a manifold assembly including a rigid manifold having at least one chamber, the rigid manifold configured and arranged to be abutted against the actuation surface for operation, wherein the at least one pair of capacitive sensing plates is positioned to be operable with the at least one chamber; a peristaltic pump tube; and a control unit configured to actuate the peristaltic pump actuator to pump an amount of dialysis fluid to the at least one chamber, receive a signal from the pair of capacitive sensing plates, count a number of revolutions of the peristaltic pump actuator, determine a current volume per revolution for the peristaltic pump actuator, and use the current volume per revolution for a subsequent operation of the peristaltic pump actuator.
A peritoneal dialysis system includes a housing; a dialysis fluid pump housed by the housing; a patient line extendable from the housing; and a hose reel located within the housing, the hose reel configured to coil the patient line when disconnected from a patient. The patient line may be a dual lumen patient line, wherein the dual lumen patient line is coiled about the hose reel during a disinfection sequence for disinfecting the dual lumen patient line and the dialysis fluid pump.
A peritoneal dialysis (“PD”) system includes a dialysis fluid pump having a reusable pump body that accepts PD fluid for pumping; a dialysis fluid inline heater including a reusable heater body that accepts PD fluid for heating; a patient line connector; a drain line connector; a first reusable PD fluid line including a first connector configured to mate with the patient line connector; a second reusable PD fluid line including a second connector configured to mate with the drain line connector; and a control unit configured to run a heat cleaning (e.g., heat disinfection or heat sterilization) sequence after PD treatment, wherein the first connector of the first reusable PD fluid line is mated with the patient line connector, the second connector of the second reusable PD fluid line is mated with the drain line connector, and the dialysis fluid pump and perhaps the dialysis fluid inline heater are actuated.
A water preparation apparatus for determining an amount of total chlorine in purified water is disclosed. The water preparation apparatus includes a chlorine sensing system, a water pretreatment filter, a reverse osmosis filter, and an electrodeionization (“EDI”) module. The chlorine sensing system is configured to determine an amount of total chlorine in the purified water by applying, at a first time, a source voltage to the purified water and removing, at a second time, the source voltage. The chlorine sensing system then measures, after the second time, an electrical parameter of the purified water. The chlorine sensing system determines the amount of total chlorine in the purified water based on the measured electrical parameter.
A mobile dialysis fluid generation system includes a cargo unit configured to be transported by a vehicle; a cleanroom located inside the cargo unit; water purification equipment; at least one dialysis fluid preparation unit located inside the cleanroom; and at least one area provided outside the cleanroom but inside the cargo unit for storing at least one of a raw material or containers filled with dialysis fluid. The at least one dialysis fluid preparation unit includes at least one concentrate, a mixing device configured to receive purified water from the water purification equipment and to mix the purified water with the at least one concentrate to form dialysis fluid, and a tubing set for transfer of the dialysis fluid from the mixing device to a container positioned and arranged to receive the dialysis fluid.
The invention provides a sensor for measuring both impedance and ECG waveforms that is configured to be worn around a patient's neck. The sensor features 1) an ECG system that includes an analog ECG circuit, in electrical contact with at least two ECG electrodes, that generates an analog ECG waveform; and 2) an impedance system that includes an analog impedance circuit, in electrical contact with at least two (and typically four) impedance electrodes, that generates an analog impedance waveform. Also included in the neck-worn system are a digital processing system featuring a microprocessor, and an analog-to-digital converter. During a measurement, the digital processing system receives and processes the analog ECG and impedance waveforms to measure physiological information from the patient. Finally, a cable that drapes around the patient's neck connects the ECG system, impedance system, and digital processing system.
An infusion pump includes a housing with a door pivotally mounted to the housing, a tube channel on the housing configured to hold a tube in the infusion pump, a pumping mechanism including a shuttle, and a slide clamp ejection device.
A61M 5/168 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
A61M 5/50 - Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile
A61M 39/28 - Clamping means for squeezing flexible tubes, e.g. roller clamps
47.
POLYMERIC COMPOSITIONS, DELIVERY DEVICES, AND METHODS
Polymeric compositions, methods, and delivery devices for inhibiting bleeding are disclosed. The method includes applying a dried material topically to a wound site, where the material may include a cross-linked biologically compatible polymer which forms a hydrogel when exposed to blood and where the material may not include an active agent such as thrombin. A spring-loaded delivery device as described herein may be used to apply the dried material.
The invention relates to a medical product for preventing or correcting vitamin A deficiency in a patient comprising a lipid emulsion in a flexible container, the lipid emulsion comprising (a) vitamin A in the lipid phase of the lipid emulsion, (b) optionally additionally vitamin D, vitamin E and/or vitamin K in the lipid phase of the lipid emulsion, and (c) no more than 1.5 ppm dissolved oxygen (DO), (d) wherein the pH of the lipid emulsion is from 5 to 9.
A61K 47/44 - Oils, fats or waxes according to two or more groups of ; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61K 47/12 - Carboxylic acids; Salts or anhydrides thereof
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
49.
DIALYSIS MACHINE, MEDICAL EQUIPMENT, AND METHODS FOR ESTABLISHING SECURE COMMUNICATION BETWEEN A DIALYSIS MACHINE AND MEDICAL EQUIPMENT
The present disclosure relates to establishing secure communication between a dialysis machine and medical equipment. In an example, a dialysis machine includes a control unit configured to establish a short-range wireless connection with external medical equipment. The control unit establishes the short-range wireless connection by causing a user interface to display a prompt to enter a passkey associated with medical equipment, using the received passkey to pair with the medical equipment, and creating a new bonding table or writing to an empty bonding table using the passkey. The control unit is also configured to generate a shared key using the passkey and at least one predetermined criterion and use the shared key to authenticate with the medical equipment. When authentication with the medical equipment is successful, the control unit enables data communication using the short-range connection with the medical equipment.
H04L 9/32 - Arrangements for secret or secure communications; Network security protocols including means for verifying the identity or authority of a user of the system
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
A medical fluid delivery system and apparatus for remote machine updating and control are disclosed. An example medical fluid delivery apparatus includes a processor and a dialysis fluid circuit including at least one dialysis fluid pump. The processor determines a dialysis treatment or a preprogrammed task is not being performed by the least one dialysis fluid pump. After determining a dialysis treatment or a preprogrammed task is not being performed, the processor activates a connectivity agent to communicatively couple to a server via a network. The processor then receives, from the server via the connectivity agent, a command message to perform a preprogrammed task. The processor next deactivates the connectivity agent to stop communication with the server and causes the at least one dialysis fluid pump to perform the preprogrammed task.
A peritoneal dialysis (“PD”) system includes a PD fluid pump; a patient line for receiving used PD fluid pumped by the PD fluid pump during a patient drain; a pressure sensor positioned and arranged to sense a negative pressure associated with the PD fluid pumped during the patient drain; and a control unit configured to (i) determine or know a flowrate of the PD fluid pumped during the patient drain, (ii) determine an applied negative pressure at which the PD fluid pump is to pump the PD fluid during the patient drain, the applied pressure based on a pressure drop corresponding to the determined or known flowrate, and (iii) use sensed negative pressure from the pressure sensor to cause the PD fluid pump to pump the PD fluid during the patient drain at the applied negative pressure.
A method and a system (10a) comprising an integrated water purifying apparatus (110) with a pre-filter circuit (402) including a particle filter and an activated carbon filter for producing pre-treated water; a fluid circuit (404) arranged to receive pre-treated water from the pre-filter circuit (402), the fluid circuit (404) includes an RO-pump (450) and a Reverse Osmosis, RO, device, (301) arranged to produce purified water; a heating device (302) arranged to heat purified water to a temperature above 65° C.; the water purifying apparatus (110) further arranged to heat disinfect the fluid circuit (404) using the heated purified water. The system further comprises a line set (40) connected to the purified water outlet connector (128) at a water line connector (68), the line set (40) including at least one sterile sterilizing grade filter (70a, 70b) arranged to filter the purified water into sterile purified water.
B05B 7/24 - Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas with means, e.g. a container, for supplying liquid or other fluent material to a discharge device
B05B 7/04 - Spray pistols; Apparatus for discharge with arrangements for mixing liquids or other fluent materials before discharge
54.
SYSTEM FOR PERITONEAL DIALYSIS AND EXTRACORPOREAL BLOOD TREATMENTS
A dialysis system is disclosed that enables a patient to undergo both peritoneal dialysis and extracorporeal blood treatments. The system includes a base unit and a blood treatment unit configured to perform extracorporeal blood treatments on a patient. The blood treatment unit includes a user interface operable with a controller for displaying a calendar of days in which an extracorporeal blood treatment is scheduled to be performed. The base unit includes a base unit controller that is programmed to receive information indicative whether a peritoneal dialysis treatment or the extracorporeal blood treatment is to be performed. The base unit controller operates first software instructions when the base unit uses a first fluid stored in a fluid container when the peritoneal dialysis treatment is selected or operates second software instructions when the base unit uses a second, different fluid from an online source when the extracorporeal blood treatment is selected.
A61M 1/34 - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration
G16H 20/40 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
A61M 60/279 - Peristaltic pumps, e.g. roller pumps
55.
WIRELESS, INTERNET-BASED SYSTEM FOR MONITORING LYMPHEDEMA
The invention provides a system for characterizing fluids in a tissue located in a portion of a patient. The system features an impedance system that includes a current-injecting electrode that injects an electrical current into the portion of the patient and a signal-measuring electrode that measures an impedance signal affected by the injected electrical current and an amount of the fluids. At least one of the electrodes includes an alignment feature that, during use, is aligned on the portion using a marking on the portion. The system also includes a processing system that receives the impedance signal from the impedance system or a signal determined from it. It then processes the signal to determine a parameter related to the degree of fluids in the tissue. The marking, for example, can be a permanent or semi-permanent marking, such as a tattoo.
A medical fluid management assembly includes a pneumatic manifold, a pump engine, a valve engine, and a fluid manifold. The pneumatic manifold includes a plurality of pneumatic passageways and a plurality of pneumatic connectors. The pump engine includes a pump chamber and the valve engine includes a valve chamber. Each of the pump engine and valve engine includes a pneumatic connector mated sealingly and releaseably with one of the pneumatic connectors of the pneumatic manifold. Additionally, each of the pump engine and valve engine includes a fluid connector. The fluid manifold includes a plurality of fluid pathways and a plurality of fluid connectors mated sealingly and releaseably with the fluid connectors of the pump engine and the valve engine.
A capacitive priming sensor for a medical fluid delivery system is disclosed. In an example embodiment, a priming sensor includes a housing including a recessed section configured to accept a portion of a patient tube. The housing includes a first electrode located adjacent to a portion of the patient tube when the portion of the patient tube is inserted into the housing and a second electrode located above the first electrode. The priming sensor also includes a capacitive sensor that measures a capacitance between the first electrode and the second electrode. A processor operates with the capacitive sensor and is configured to use the measured capacitance to determine a transition between a dry tube state and a wet tube state. The processor then causes a pump to stop pumping dialysis fluid through the patient tube for the priming sequence after the wet tube state is determined.
A medical fluid system includes a medical fluid pump configured to pump a medical fluid; electronics associated with the medical fluid pump or with other components of the medical fluid system; a thermoelectric heater positioned and arranged to heat medical fluid pumped by the medical fluid pump, the thermoelectric heater including a heated side and a cooled side; a heat exchanger through which medical fluid pumped by the medical fluid pump is heated, the heat exchanger positioned and arranged so as to be in thermal communication with the heated side of the thermoelectric heater; and a mounting plate, the electronics supported by the mounting plate, the mounting plate positioned and arranged so as to be in thermal communication with the cooled side of the thermoelectric heater.
A61M 1/00 - Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
A peritoneal dialysis system includes a cycler having one or more air pump; a slotted housing including a plurality of slots each having a first side and a second side, wherein each respective slot of the plurality of slots includes a first expandable bladder fixed to the first side, and wherein each respective slot of the plurality of slots is configured to receive a fluid supply bag between the first expandable bladder and the second side, and a heater housing sized to hold a second expandable bladder, and wherein the heater housing is configured to receive a fluid heater bag adjacent to the second expandable bladder, wherein the one or more air pump is in fluid communication with the respective first expandable bladders and the second expandable bladder; and a disposable set operable with the cycler.
A wearable automated peritoneal dialysis (“APD”) machine is disclosed herein. In an example, the APD machine includes a delivery system connected to a dialysis fluid container and a catheter connected to a peritoneal cavity of a patient. The delivery system includes a pump for pumping fresh dialysis fluid from the dialysis fluid container to the patient, and pumping used dialysis fluid from the patient to the dialysis fluid container. The delivery system also includes a control unit configured to control the pump using a flow rate measured by a flow sensor and a pressure measured by a pressure sensor. The APD machine also includes a clothing item to be worn by the patient. The clothing item includes a first section to retain the dialysis fluid container, a heating element positioned adjacent to the first section for warming the fresh dialysis fluid, and a second section to retain the delivery system.
A peritoneal dialysis system comprises a cycler including an air pump; a heater housing including a heater and an expandable bladder in fluid communication with the air pump, wherein the heater housing is sized to receive a heater bag between a wall of the housing and the expandable bladder; a plurality of nesting containers configured for fluid communication with the air pump a disposable set operable with the cycler and including the heater bag and a plurality of fluid supply bags for placement within the plurality of nesting containers; and a control unit programmed to control the air pump and the heater.
A peritoneal dialysis (“PD”) system includes a cycler having a micropump actuator, a pressure transducer, and at least one valve actuator; a disposable set including a micropump head sized and shaped for mating with and being driven by the micropump actuator, a pressure sensor configured to operably communicate with the pressure transducer, and at least one fluid valve portion or a portion of at least one fluid line for interfacing with the at least one valve actuator; and a control unit, wherein the disposable set may be arranged to allow, and the control unit may be programmed to operate the micropump actuator and the at least one valve actuator, so that fresh and used dialysis fluid flows through the micropump head in a same direction. The system may also dampen pressure fluctuations via pressure pods, and may analyze the outputs from the pressure pods for patient empty and occlusion detection.
A peritoneal dialysis system includes: a bellows; a common inlet/outlet fluid receptacle in fluid communication with the bellows; a plurality of fluid lines in fluid communication with the common inlet/outlet line; a linear actuator positioned and arranged to expand and compress the bellows; a plurality of valves positioned and arranged to allow or occlude flow through the plurality of fluid lines to or from the bellows; and a control unit configured to control the linear actuator and the plurality of valves.
A platform for patient engagement and treatment compliance is disclosed. In an example, a system includes a home therapy machine configured to perform a renal failure therapy treatment. The system also includes a mobile communication device including an application having a calendar feature that identifies times/days in which the renal failure therapy treatment is scheduled to be performed. The application is configured to use the calendar feature to determine a time/day of a next scheduled renal failure therapy treatment. At a designated time before the next scheduled renal failure therapy treatment, the application causes a display interface of the personal mobile communication device to display a prompt for medical information. When the medical information is not received before the next scheduled renal failure therapy treatment, the application causes the home therapy machine to delay a start of the next scheduled renal failure therapy treatment.
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 80/00 - ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
G06K 19/06 - Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code
The present disclosure relates to parenteral nutrition formulations, including ready-to-use parenteral nutrition formulations which are reconstituted from multi-chamber containers and amino acid formulations. More particularly, the present disclosure is directed to formulations comprising butyrate derivatives, specifically arginine butyrate, for use with adult or pediatric patients. The disclosure further provides for methods of reducing or preventing systemic and local inflammation of patients receiving parenteral nutrition, and methods of maintaining or ameliorating their systemic immunity and local immunity, as well as the patients' gut barrier functions.
A23L 33/125 - Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing starch hydrolysates
A23L 33/00 - Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
A61J 1/05 - Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids
A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
A61K 47/42 - Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
A61K 47/44 - Oils, fats or waxes according to two or more groups of ; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
66.
PERITONEAL DIALYSIS CYCLER HAVING DECREASED PH DISINFECTION
A peritoneal dialysis (“PD”) system includes a plurality of PD fluid components, a reusable PD fluid line selectively fluidly communicating with the PD fluid components, a source of PD fluid selectively fluidly communicating with the reusable PD fluid line, a source of anti-scaling fluid selectively fluidly communicating with the reusable PD fluid line, and a control unit configured to (i) operate the plurality of PD fluid components during treatment using PD fluid from the source heated to a treatment temperature, and (ii) circulate unused PD fluid heated to a disinfection temperature in combination with anti-scaling fluid from the source of anti-scaling fluid after treatment for disinfecting the plurality of PD fluid components and the reusable PD fluid line, the anti-scaling fluid provided in an amount configured to lower the pH of the unused PD fluid to a level below which precipitates are formed and above which the pH causes disinfection.
A parenteral nutritional diagnostic system, apparatus, and method are disclosed. In an example, a parenteral nutritional diagnostic apparatus determines muscle quantity and muscle quality of a patient's psoas muscle to determine a nutritional status of the patient. An image interface is configured to receive a medical image including radiodensity data related to imaged tissue of the patient. The apparatus also includes a processor configured to use the medical image to determine a tissue surface area for each different value of radiodensity and determine a distribution of the tissue surface area for each radiodensity value. The processor is configured to determine muscle quality by locating a soft tissue peak within the distribution that corresponds to a local peak in at a region related to at least one of muscle tissue, organ tissue, and intramuscular adipose tissue. The processor determines the nutritional status of the patient based on the soft tissue peak.
G16H 30/20 - ICT specially adapted for the handling or processing of medical images for handling medical images, e.g. DICOM, HL7 or PACS
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
G16H 20/60 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
G16H 30/40 - ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
68.
OPTIMIZING PERITONEAL DIALYSIS USING A PATIENT HAND-HELD SCANNING DEVICE
A handheld personal communication apparatus for dialysis includes a reader to read a marking displayed on a dialysis fluid container to acquire data concerning a dialysis fluid type. The apparatus also includes a processor that uses the dialysis fluid type to determine a dialysis dwell time for at least one cycle of a dialysis therapy, the dialysis dwell time being a time to achieve, over the at least one cycle, at least one of (a) a specified ultrafiltrate level, (b) a urea removal level, or (c) a creatinine removal level. The apparatus further includes an output interface that provides an indication to the patient of a completion of the dialysis dwell time.
G16H 10/65 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records stored on portable record carriers, e.g. on smartcards, RFID tags or CD
G16H 20/40 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
69.
DETERMINATION OF OXIDIZING SUBSTANCES USING PEPTIDE DEGRADATION
An analytical method for detecting presence of oxidizing substances by measuring degradation of peptides may include preparing a test preparation that includes a peptide and a sample. The peptide degrades in the presence of oxidizing substances. The method may include detecting impurities of the peptide in the test preparation in which detected impurities indicate presence of oxidizing substances in the sample. Examples include using high performance liquid chromatography to detect, identify, and quantify impurities of the peptide indicating presence of oxidizing substances in the sample. Exemplary oxidizing substances include peroxide-containing, chlorine-containing compounds, and bromine-containing compounds. Exemplary peptides include vasopressin.
Disclosed are a fibrinogen solution and a thrombin solution. The fibrinogen solution comprises fibrinogen at a concentration of at least 40 mg/ml, factor XIII, pharmaceutically acceptable additives and water. The dynamic viscosity of the fibrinogen solution measured at 20° C. increases at most by 35% after storing the solution at 20° C. for 30 days. The thrombin solution comprises thrombin, pharmaceutically acceptable additives and water. The thrombin activity decreases at most by 15% after storing the solution at 25° C. for 14 days. Also disclosed is a fibrin sealant kit with a first container comprising the fibrinogen solution and a second container comprising the thrombin solution. Further, methods for preparing a fibrin sealant and methods for treating a wound are disclosed.
A process for calibrating a glucose sensor under sterile conditions includes providing separate, sterile, glucose-containing calibration fluids, each having a different glucose concentration, and in turn providing these fluids to a sensing zone containing a sensing probe of a glucose sensor. Each solution is typically, in turn, propelled into the sensing zone, thus flushing out used fluid already present in the sensing zone. The process provides rapid calibration of a glucose sensor in a sterile fashion and is therefore appropriate for point-of-use calibration.
A61B 5/1495 - Calibrating or testing in vivo probes
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
A61B 5/1459 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
A system and method for securing a pump are disclosed. The system includes a pump that contains a medicament delivery system, a processor operably coupled to the pump, a user interface in operable communication with the processor, a plurality of sensors in operable communication with the processor, and a housing. The housing includes a frame, a door, and a locking mechanism that can be selectively unlocked to allow the door to partially detach from the frame. The security system includes a swivel door assembly, which includes physical redundancies to selectively prevent access to the internal space of the swivel door assembly and a plurality of alarms. For example, in response to receiving an input from the plurality of sensors, the processor initiates at least one of the plurality of alarms to provide an indication to a user that an event has occurred.
A pharmaceutical premix formulation comprising from about 10 mcg/ml to about 70 mcg/ml epinephrine and a salt is described, wherein the formulation is an aqueous, premix formulation and has a pH from about 2 to about 6. Uses and systems including the epinephrine premix formulation are also provided.
The present disclosure is directed to a midazolam pharmaceutical premix formulation housed in a flexible container, comprising from about 0.4 mg/ml to about 1.1 mg/ml midazolam hydrochloride and sodium chloride, wherein the formulation has a pH from about 2.7 to about 3.5. Also disclosed herein are methods of sedating a human subject in need thereof using the premix formulation.
A61K 31/5517 - 1,4-Benzodiazepines, e.g. diazepam condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
A method and a system comprising an integrated water purifying apparatus with a pre-filter circuit including a particle filter and an activated carbon filter arranged to produce pre-treated water; a fluid circuit arranged to receive pre-treated water from the pre-filter circuit, the fluid circuit including an RO-pump and a Reverse Osmosis (RO) device arranged to produce purified water; a heating device arranged to heat purified water from the RO device to a temperature above 65°0 C.; the water purifying apparatus further arranged to heat disinfect the fluid circuit using the heated purified water. The system further comprises a line set connected to the purified water outlet connector at a water line connector of the line set, wherein the line set includes at least one sterile sterilizing grade filter arranged to further filter the purified water.
A peritoneal dialysis (“PD”) system includes a PD fluid pump; a disinfection loop including the PD fluid pump, the disinfection loop including PD fluid used for disinfecting the disinfection loop; and a carbon dioxide (CO2), source positioned and arranged to supply CO2 to the disinfection loop to inhibit and/or remove the production of calcium carbonate (CaCO3) during a disinfection sequence. The PD system includes a control unit configured to open a valve to allow CO2 to be supplied, wherein the control unit may use a lookup table or algorithm to determine the desired pressure or pressure increase.
The invention provides a system for characterizing a patient including a substrate, a first electrode, a second electrode, and an electrical system. The electrical system is connected to the substrate and worn entirely on the patient's body. The electrical system in electrical contact with both the first and second electrodes and configured to inject an alternating electrical current through the first electrode and into the region of tissue. The electrical system is configured to measure a first electrical signal from the region of tissue through the second electrode. The electrical system is configured to measure a second electrical signal from the region of tissue. The first electrical signal or a signal determined therefrom indicates a resistance of the region of tissue and the second electrical signal or a signal determined therefrom indicates a reactance of the region of tissue.
The present disclosure is directed to a pharmaceutical premix phenylephrine formulation comprising phenylephrine hydrochloride and a salt, e.g., sodium chloride, where the formulation has a pH from about 3.0 to 6.5. Also presented is a system containing an oxygen scavenger, a photosensitive overpouch, and a pharmaceutical premix phenylephrine formulation. Methods of treating hypotension, e.g., resulting primarily from vasodilation, in such settings as septic shock or anaesthesia, in a human subject are also described.
A peritoneal dialysis system includes a control unit configured to cause (i) a fluid inlet valve and a fluid outlet valve to occlude a fluid inlet line and a fluid outlet line, respectively, while a linear actuator moves a piston to create a positive pressure within a pump housing, the positive pressure measured by a pressure sensor, and (ii) the fluid inlet valve to occlude the fluid inlet line and the fluid outlet valve to open the fluid outlet line, while the linear actuator moves the piston so as to maintain the positive pressure within the pump housing while fluid is pumped out of the fluid pump chamber via the opened fluid outlet line.
A peritoneal dialysis (“PD”) system having an air-aided pumping sequence is disclosed herein. In an example, a PD system includes a housing, a PD fluid pump housed by the housing, an airtrap, a fluid line extending from the airtrap, a fluid line valve positioned and arranged to operate with the fluid line, a gas line extending from an upper portion of the airtrap, and a gas line valve positioned and arranged to operate with the gas line. The system also includes a control unit configured to cause the fluid line valve to close, the gas line valve to open, and the PD fluid pump to pump gas from the airtrap into the gas line after a patient drain to create a pocket of gas in the fluid line and push residual used PD fluid towards a drain line.
A tube occluder includes a body within which an end of the tube is attached; a twisting lug formed with or attached to the tube, the twisting lug including an outwardly extending shape; and a sleeve in rotational communication with the body, the sleeve including an internal profile that matingly engages the outwardly extending shape of the twisting lug, the sleeve rotatable relative to the body in a first direction such that the internal profile causes the twisting lug to twist the tube closed, the sleeve rotatable in a second direction such that the internal profile causes the twisting lug to twist the tube open. A tube occluding method includes enabling a user to rotate the sleeve relative to the body, causing the internal profile to turn the twisting lug and to twist the tube closed while the end of the tube remains secured within the body.
A packaged, sealed container system for stable storage of a formulation of an oxygen-sensitive pharmaceutical compound, the packaged, sealed container system comprising a primary container including therein a formulation of an oxygen-sensitive pharmaceutical compound, a secondary outer container comprising a first flexible sheet layer, an opposing second flexible sheet layer, and a seal disposed along a common peripheral edge of the first and second flexible sheet layers, such that the primary container is disposed between and enclosed by the first and second flexible sheet layers of the secondary outer container. An oxygen scavenger is also disposed between and enclosed by the first and second flexible sheet layers of the secondary outer container. The oxygen scavenger is in fluid communication with the contents of the primary container.
A61M 5/00 - Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
B65D 75/28 - Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
B65D 81/26 - Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
84.
Virtual assistant/chatbot to improve clinical workflows for home renal replacement therapies
A virtual assistant/chatbot to improve clinical workflow for home renal replacement therapies is disclosed herein. A virtual assistant/chatbot includes a patient-facing user interface configured to enable a patient to engage in a virtual chat session by typing, speaking, or otherwise providing information regarding a patient request or issue related to their renal replacement therapy. The virtual assistant/chatbot also includes a backend server-based system configured to provide logic to respond to a patient's requests. The logic defines a sequence of questions and answers for resolving patient queries. The sequence of assistant/chatbot questions and patient answers may be configured in a node arrangement such that certain patient answers/requests lead to additional questions for additional information from a patient. The virtual assistant/chatbot is configured to answer patient requests automatically or determine if the patient request is to be immediately addressed by a clinician or later through a phone call, text, or email communication.
G16H 10/20 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
G10L 15/22 - Procedures used during a speech recognition process, e.g. man-machine dialog
H04L 51/02 - User-to-user messaging in packet-switching networks, transmitted according to store-and-forward or real-time protocols, e.g. e-mail using automatic reactions or user delegation, e.g. automatic replies or chatbot-generated messages
H04L 67/10 - Protocols in which an application is distributed across nodes in the network
A peritoneal dialysis system and method includes a control unit configured to enable a pressurization device to pressurize a pressure cavity to a pressure; cause a fluid valve to be opened when the pressure reaches a desired pressure to allow fluid communication with a flexible container located within the pressure cavity; cause a pressure within the pressure cavity to be measured after the fluid valve is opened; and determine that the flexible container is full of fluid or empty of fluid if the pressure within the pressure cavity after the fluid valve is opened becomes or remains at least substantially constant.
A flexible multi-chamber bag for storing and reconstituting parenteral nutrition solutions is disclosed. The flexible multi-chamber bag comprises two first peelably sealing walls between the two polymer films extending from the top edge to the bottom edge and separating the first bag into a first chamber, a second chamber and a third chamber, wherein the first chamber is between the second chamber and the third chamber; and at least one of the two first peelably sealing walls split into a second plurality of second peelably sealing walls and the second plurality of the second sealing walls sealed to the bottom edge to form a fourth chamber.
B65B 3/00 - Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans or jars
89.
INJECTION SITE WITH A MEMBRANE AND A LEAK-FREE REMOVABLE PROTECTION
A medical device for transferring a fluid from a pharmaceutical flexible container is disclosed. The medical device comprises a top part, a center part, a breakable zone between the top part and the center part and an insert part. The insert part comprises a third enclosure enclosing a second tunnel; and the top side of the third enclosure comprising a membrane, wherein a top surface of the membrane seals the third opening of the second enclosure.
A flexible multi-chamber bag for storing and reconstituting parenteral nutrition solutions is disclosed. The flexible multi-chamber bag comprises a first peelably sealing wall and a second peelably sealing wall between the two polymer films extending from the top edge to the bottom edge and separating the first bag into a first chamber between the first peelably sealing wall and the second peelably sealing wall, a first space between the left edge and the first peelably sealing wall, a second space between the second peelably sealing wall and the right edge; a third peelably sealing wall extending from the left edge to the first peelably sealing wall to separate the first space to form a third chamber and a fourth chamber; and a fourth peelably sealing wall extending from the right edge to the second peelably sealing wall to separate the second space to form a second chamber and a fifth chamber.
A fluid delivery system includes a fluid pump; a pressure sensor for sensing pressure of fluid pumped by the fluid pump, wherein an output from the pressure sensor varies depending upon whether medical fluid or air is pumped during a pump stroke of the medical fluid pump; and a control unit configured to use the output from the pressure sensor to determine whether medical fluid or air is present during the pump stroke.
A61F 2/00 - Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
A dialysis system includes a dialysis fluid metering pump; at least one volumetric balancing chamber including a first fixed volume chamber and a first diaphragm positioned and arranged to extend back and forth within the first volumetric balancing chamber; a first outlet line extending between the first volumetric balancing chamber and an inlet to the dialysis fluid metering pump; a second outlet line extending between the first volumetric balancing chamber and a drain line; a first inlet line extending between the first volumetric balancing chamber and an outlet from the dialysis fluid metering pump; a second inlet line extending between the first volumetric balancing chamber and a used dialysis fluid line.
A peritoneal dialysis system includes a control unit configured to (i) store a sleep state pattern for the patient, (ii) begin a patient drain followed by a patient fill when at least one sensor indicates that the patient is in a deep sleep state, (iii) extend a dwell period if the sleep state pattern indicates that the patient will enter a subsequent deep sleep state within a first time duration after a programmed dwell period, and (iv) shorten the dwell period if the sleep state pattern indicates that the patient will leave the deep sleep state within a second time duration after an end of the programmed dwell period. The system alternatively or additionally assesses or records a stress level of and/or a fluid/caloric intake by the patient and takes actions accordingly.
A peritoneal dialysis (“PD”) system includes a first volumetric balancing chamber including a first fixed volume chamber and a first diaphragm positioned and arranged to extend back and forth within the first fixed volume chamber, the first diaphragm separating a fresh PD fluid side from a used PD fluid side of the first volumetric balancing chamber; a second volumetric balancing chamber including a second fixed volume chamber and a second diaphragm positioned and arranged to extend back and forth within the second fixed volume chamber, the second diaphragm separating a fresh PD fluid side from a used PD fluid side of the second volumetric balancing chamber; and a PD fluid pump positioned and arranged to pump used PD fluid back and forth between the used PD fluid sides of the first and second volumetric balancing chamber.
A peritoneal dialysis (“PD”) system includes a housing; a PD fluid pump housed by the housing; a dual lumen patient line extending from the housing, the dual lumen patient line including a fill lumen and a return lumen; a PD fluid fill line in fluid communication with the fill lumen and an outlet of the PD fluid pump; a PD fluid return line in fluid communication with the return lumen and an inlet of the PD fluid pump; a fill pressure sensor configured to detect PD fluid pressure along the PD fluid fill line; a return pressure sensor configured to detect PD fluid pressure along the PD fluid return line; and a control unit configured to use outputs from the fill and return pressure sensors to determine if one of the fill lumen or the return lumen of the dual lumen patient line is occluded.
patents
